Status:

TERMINATED

A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department

Lead Sponsor:

Pfizer

Conditions:

Rheumatoid Arthritis

Ankylosing Spondylitis

Eligibility:

All Genders

18+ years

Brief Summary

This is an open-label, multicenter and observational study in China, which is designed to record the data of RA \& AS patients within 52 weeks after rheumatologists decided to prescribe etanercept, an...

Detailed Description

The primary objective of this non-interventional study is to evaluate the safety of etanercept in Chinese RA and AS subjects. Total of 600 subjects (300 RA subjects and 300 AS subjects) will be enroll...

Eligibility Criteria

Inclusion

  • Subject has a confirmed diagnosis of rheumatoid arthritis or ankylosing spondylitis.
  • Subject has accepted physician's prescription of etanercept in rheumatology department.
  • Subject agreed to be enrolled in the observational study and sign the ICD.
  • Subject is≥18 years of age at the time of consent.
  • Subject is willing and able to understand and complete questionnaires

Exclusion

  • Presence of active or suspected latent infection including HIV, or any underlying disease, including open cutaneous ulcers that could predispose the subject to infections.
  • Immunodeficiency syndromes including Felty syndrome or large granular lymphocyte syndrome.
  • Active tuberculosis (TB) or a history of TB, or findings consistent with previous exposure to TB on a chest x-ray (CXR). Investigators must follow China's guidelines for appropriate screening and treatment of TB.
  • History of hypersensitivity to any of the ingredients in either preparation.

Key Trial Info

Start Date :

January 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 1 2013

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT01411215

Start Date

January 1 2011

End Date

January 1 2013

Last Update

March 6 2014

Active Locations (15)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (15 locations)

1

Daping Hospital

Chongqing, Chongqing Municipality, China, 400038

2

Fujian Provincial Hospital

Fuzhou, Fujian, China, 350001

3

Lanzhou University Second Hospital

Lanzhou, Gansu, China, 730030

4

The First Affiliated Hospital of Guangzhou University of Chinese Medicine

Guangzhou, Guangdong, China, 510405